Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients.
Diagnostic parameters
Idiopathic inflammatory myopathies
Multiplex assay
Myositis
Validation
Journal
Journal of translational autoimmunity
ISSN: 2589-9090
Titre abrégé: J Transl Autoimmun
Pays: Netherlands
ID NLM: 101759413
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
31
05
2019
revised:
25
07
2019
accepted:
29
07
2019
entrez:
4
8
2020
pubmed:
4
8
2020
medline:
4
8
2020
Statut:
epublish
Résumé
Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of connective tissue diseases, collectively known as myositis. Diagnosis of IIM is challenging while timely recognition of an IIM is of utter importance considering treatment options and otherwise irreversible (severe) long-term clinical complications. With the EULAR/ACR classification criteria (2017) considerable advancement has been made in the diagnostic workup of IIM. While these criteria take into account clinical parameters as well as presence of one autoantibody, anti-Jo-1, several autoantibodies are associated with IIM and are currently evaluated to be incorporated into classification criteria. As individual antibodies occur at low frequency, the development of line blots allowing multiplex antibody analysis has improved laboratory diagnostics for IIM. The Euroline myositis line-blot assay (Euroimmun) allows screening and semi-quantitative measurement for 15 autoantibodies,
Identifiants
pubmed: 32743501
doi: 10.1016/j.jtauto.2019.100013
pii: S2589-9090(19)30013-9
pii: 100013
pmc: PMC7388388
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100013Informations de copyright
© 2019 The Authors.
Références
J Eur Acad Dermatol Venereol. 2018 Jul;32(7):1164-1172
pubmed: 29237090
Autoimmunity. 2018 Mar;51(2):89-95
pubmed: 29463118
Arthritis Rheumatol. 2017 Dec;69(12):2271-2282
pubmed: 29106061
Curr Opin Rheumatol. 2012 Nov;24(6):602-8
pubmed: 22955022
Ann Rheum Dis. 2018 Nov;77(11):e77
pubmed: 29170201
Pathology. 2016 Jun;48(4):363-6
pubmed: 27114370
Arthritis Res Ther. 2017 Nov 25;19(1):259
pubmed: 29178913
Clinics (Sao Paulo). 2013 Jul;68(7):909-14
pubmed: 23917652
Curr Opin Rheumatol. 2018 Nov;30(6):637-643
pubmed: 30074509
Autoimmun Rev. 2009 Sep;9(1):58-61
pubmed: 19285154
J Autoimmun. 2017 Sep;83:95-112
pubmed: 28739356
Rheumatology (Oxford). 2019 Apr 1;58(4):650-655
pubmed: 30535395
Ann Rheum Dis. 2019 Jan;78(1):e7
pubmed: 29371203
Pract Neurol. 2019 Aug;19(4):284-294
pubmed: 30826741
Arthritis Care Res (Hoboken). 2013 Aug;65(8):1307-15
pubmed: 23436757
Nat Rev Rheumatol. 2018 May;14(5):269-278
pubmed: 29651121
Rheumatology (Oxford). 2010 Dec;49(12):2370-4
pubmed: 20724434
Autoimmun Rev. 2019 Mar;18(3):293-305
pubmed: 30639643
Autoimmun Rev. 2009 Jun;8(7):543-8
pubmed: 19200856
Int J Rheum Dis. 2016 Oct;19(10):996-1001
pubmed: 26621603
Clin Exp Rheumatol. 2014 Nov-Dec;32(6):891-7
pubmed: 25151986
J Neurol. 2019 Jun;266(6):1358-1366
pubmed: 30840145
J Intern Med. 2016 Jul;280(1):8-23
pubmed: 26602539
JAMA Neurol. 2018 Dec 1;75(12):1528-1537
pubmed: 30208379
Front Immunol. 2015 Jun 25;6:331
pubmed: 26161084
Ann Rheum Dis. 2018 Nov;77(11):e78
pubmed: 29247124
Lung. 2018 Jun;196(3):329-333
pubmed: 29532165
Ann Rheum Dis. 2018 Jan;77(1):30-39
pubmed: 28855174
J Clin Lab Anal. 2016 Nov;30(6):859-866
pubmed: 27074881
J Immunol Methods. 2016 Jun;433:1-5
pubmed: 26906088
Clin Exp Dermatol. 2017 Aug;42(6):659-662
pubmed: 28639716
J Autoimmun. 2019 Jul;101:48-55
pubmed: 30992170
Curr Rheumatol Rep. 2018 Oct 31;20(12):78
pubmed: 30382445